SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-001367
Filing Date
2024-03-07
Accepted
2024-03-07 06:30:11
Documents
18
Period of Report
2024-03-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT avid_8k.htm   iXBRL 8-K 35746
2 PRESS RELEASE ANNOUNCING CERTAIN PRELIMINARY FINANCIAL RESULTS, DATED MARCH 6, 2 avid_ex9901.htm EX-99.1 19580
3 PRESS RELEASE ANNOUNCING CONVERTIBLE NOTE OFFERING, DATED MARCH 6, 2024 avid_ex9902.htm EX-99.1 9282
4 PRESS RELEASE ANNOUNCING PRICING OF CONVERTIBLE NOTE OFFERING, DATED MARCH 6, 20 avid_ex9903.htm EX-99.1 10705
8 GRAPHIC image_001.jpg GRAPHIC 10051
  Complete submission text file 0001683168-24-001367.txt   276593

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cdmo-20240306.xsd EX-101.SCH 3012
6 XBRL LABEL FILE cdmo-20240306_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE cdmo-20240306_pre.xml EX-101.PRE 22357
19 EXTRACTED XBRL INSTANCE DOCUMENT avid_8k_htm.xml XML 3494
Mailing Address 14191 MYFORD ROAD TUSTIN CA 92780
Business Address 14191 MYFORD ROAD TUSTIN CA 92780 714.508.6100
Avid Bioservices, Inc. (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-32839 | Film No.: 24728061
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)